ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 140 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $50,000 | +8.7% | 10,600 | 0.0% | 0.00% | – |
| Q3 2019 | $46,000 | -94.9% | 10,600 | -93.2% | 0.00% | -100.0% |
| Q2 2019 | $906,000 | -54.0% | 155,400 | -69.6% | 0.00% | -83.3% |
| Q1 2019 | $1,970,000 | +139.7% | 511,600 | +16.4% | 0.01% | +100.0% |
| Q4 2018 | $822,000 | -23.6% | 439,600 | +159.2% | 0.01% | 0.0% |
| Q1 2017 | $1,076,000 | +75.8% | 169,600 | +48.3% | 0.01% | +50.0% |
| Q4 2016 | $612,000 | -5.0% | 114,400 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $644,000 | – | 114,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
| Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
| MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
| Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
| Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
| Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
| Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
| PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
| Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
| G&S Capital LLC | 18,000 | $34,000 | 0.03% |